Long Road Investment Counsel, LLC Gilead Sciences, Inc. Transaction History

Long Road Investment Counsel, LLC

$251 Million
Q3 2024

A detailed history of Long Road Investment Counsel, LLC transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Long Road Investment Counsel, LLC holds 24,250 shares of GILD stock, worth $2.18 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares

24,250

Previous 24,250 -0.0%

Holding current value

$2.18 Million

Previous $1.66 Million 22.18%

% of portfolio

0.81%

Previous 0.72%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$71.58 - $87.29 $21,474 - $26,187	300 Added 1.25%	24,250 $1.78 Million
Q4 2023 Feb 08, 2024	SELL	$73.27 - $83.09 $43,962 - $49,854	-600 Reduced 2.44%	23,950 $1.87 Million
Q3 2023 Nov 13, 2023	SELL	$73.94 - $80.67 $3,697 - $4,033	-50 Reduced 0.2%	24,550 $1.84 Million
Q1 2023 May 10, 2023	SELL	$77.31 - $88.08 $30,924 - $35,232	-400 Reduced 1.6%	24,600 $2.04 Million
Q4 2022 Feb 09, 2023	SELL	$62.32 - $89.47 $37,392 - $53,682	-600 Reduced 2.34%	25,000 $2.15 Million
Q2 2022 Aug 02, 2022	BUY	$57.72 - $65.01 $34,632 - $39,006	600 Added 2.4%	25,600 $1.58 Million
Q1 2022 May 11, 2022	SELL	$57.92 - $72.58 $34,752 - $43,548	-600 Reduced 2.34%	25,000 $1.49 Million
Q4 2020 Feb 11, 2021	BUY	$56.65 - $64.55 $56,650 - $64,550	1,000 Added 4.07%	25,600 $1.49 Million
Q3 2020 Nov 12, 2020	SELL	$62.1 - $78.08 $62,100 - $78,080	-1,000 Reduced 3.91%	24,600 $1.55 Million
Q1 2020 May 05, 2020	BUY	$62.63 - $80.22 $62,630 - $80,220	1,000 Added 4.07%	25,600 $1.91 Million
Q4 2019 Feb 13, 2020	SELL	$61.62 - $67.78 $61,620 - $67,780	-1,000 Reduced 3.91%	24,600 $1.6 Million
Q1 2019 May 09, 2019	BUY	$62.53 - $70.05 $62,530 - $70,050	1,000 Added 4.07%	25,600 $1.66 Million
Q4 2018 Feb 07, 2019	SELL	$60.54 - $79.0 $18,162 - $23,700	-300 Reduced 1.2%	24,600 $1.54 Million
Q3 2018 Nov 08, 2018	SELL	$71.28 - $78.92 $7,128 - $7,892	-100 Reduced 0.4%	24,900 $1.92 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $21,852 - $26,640	-300 Reduced 1.19%	25,000 $1.89 Million
Q4 2017 Feb 13, 2018	SELL	$71.15 - $83.52 $35,575 - $41,760	-500 Reduced 1.94%	25,300 $1.81 Million
Q3 2017 Nov 13, 2017	SELL	$72.11 - $85.47 $173,064 - $205,128	-2,400 Reduced 8.51%	25,800 $2.09 Million
Q2 2017 Aug 09, 2017	BUY	N/A	28,200	28,200 $2 Million

Others Institutions Holding GILD

# of Institutions

1,924

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Long Road Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Long Road Investment Counsel, LLC with notifications on news.

Account

Long Road Investment Counsel, LLC Gilead Sciences, Inc. Transaction History